Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neuropace Inc
(NQ:
NPCE
)
9.700
+0.700 (+7.78%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neuropace Inc
< Previous
1
2
3
4
Next >
NPCE Stock Earnings: NeuroPace Beats EPS, Beats Revenue for Q4 2023
March 05, 2024
NPCE stock results show that NeuroPace beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
March 05, 2024
From
NeuroPace, Inc.
Via
GlobeNewswire
Financial Freedom Fighters: 3 Stocks to Liberate Your Portfolio
March 05, 2024
Stocks for financial freedom are generational companies that are well-run, growing fast, and focused on the future.
Via
InvestorPlace
NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
December 04, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Expert Ratings for NeuroPace
December 04, 2023
Via
Benzinga
Expert Ratings for NeuroPace
November 10, 2023
Via
Benzinga
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
NPCE Stock Earnings: NeuroPace Beats EPS, Beats Revenue for Q2 2024
August 13, 2024
NPCE stock results show that NeuroPace beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
May 09, 2024
Via
Benzinga
NPCE Stock Earnings: NeuroPace Meets EPS, Beats Revenue for Q1 2024
May 08, 2024
NPCE stock results show that NeuroPace met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
April 17, 2024
From
NeuroPace, Inc.
Via
GlobeNewswire
The Latest Analyst Ratings For NeuroPace
March 12, 2024
Via
Benzinga
Recap: NeuroPace Q4 Earnings
March 05, 2024
Via
Benzinga
Earnings Preview: NeuroPace
March 04, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On NeuroPace Through 4 Analysts
February 22, 2024
Via
Benzinga
Earnings Scheduled For March 5, 2024
March 05, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via
Benzinga
NeuroPace Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
January 30, 2024
Via
Benzinga
Breaking Down NeuroPace: 6 Analysts Share Their Views
December 27, 2023
Via
Benzinga
Earnings Scheduled For November 6, 2023
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
December 01, 2023
RNS System featured in over 50 Scientific Presentations and Posters
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Epilepsy-Focused MedTech NeuroPace Has Attractive Entry Point, Competitive Position
November 10, 2023
Cantor Fitzgerald initiated coverage on NeuroPace Inc (NASDAQ: NPCE), a commercial-stage medical device company focused on drug-resistant epilepsy treatment through the company's responsive...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
November 06, 2023
Via
Benzinga
NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
November 06, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Announces RNS System Enhancements Designed to Streamline Care
October 17, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023
October 16, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference
September 20, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Top 5 Health Care Stocks That May Fall Off A Cliff
September 06, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 29, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
